发明名称 Composition for protection against cell-damaging effects
摘要 The present invention relates to a composition consisting of Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin. The present invention relates further to the use of the composition for minimizing the cell-damaging effect of radicals and harmful forms of oxygen, in particular of oxygen radicals or reactive oxygen species. The present invention relates to a composition comprising Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin, wherein the composition is administered in a concentration ranging from 10 to 20 mg/kg body weight. The present invention relates further to the composition for use in the treatment and/or prevention of radical and harmful forms of oxygen derived diseases, in particular of oxygen radical or reactive oxygen species derived diseases. The present invention relates further to the composition as a food supplement or dietary supplement.
申请公布号 US9089548(B2) 申请公布日期 2015.07.28
申请号 US201214358365 申请日期 2012.11.15
申请人 Tima Foundation 发明人 Inufusa Haruhiko
分类号 A61K31/375;A61K31/122;A61K31/198;A61K31/455;A61K31/194;A61K31/525;A23L1/302;A23L1/305;A23L1/30;A61K31/519 主分类号 A61K31/375
代理机构 Parker Highlander PLLC 代理人 Parker Highlander PLLC
主权项 1. A method for the treatment and/or prevention of radicals and harmful forms of oxygen in a human or animal, or the treatment and/or prevention of a disease in a human or animal, said disease selected from radiation-induced gastrointestinal syndrome, anemia, ischemic reperfusion injury, inflammatory diseases, systemic lupus erythematosis, myocardial infarction, stroke traumatic hemorrhage, spinal cord trauma, Crohn's disease, rheumatoid arthritis, cataract formation, uveitis, emphysema, gastric ulcers, oxygen toxicity, neoplasia, radiation sickness, cancer, Alzheimer's disease, Parkinson's disease, hemochromatosis, deafness, atherosclerosis, psychosis, bone marrow failure, pancytopenia, fatal immune dysfunction, movement disorders and schizophrenia, comprising administering to said subject from 10 to 20 mg of a composition per kilogram of body weight of said subject comprising 3 to 5 mass % coenzyme Q10, 1 to 2 mass % riboflavin, 15 to 20 mass % L-cystine or L-cysteine, 0.5 to 1.0 mass % niacin, 28 to 43 mass % Vitamin C, 3 to 5 mass % succinic acid, 3 to 5 mass % fumaric acid and 27 to 42 mass % L-glutamine.
地址 Balzers LI